raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:67047

3-methylglutaconic aciduria type 3

Synonyms: Autosomal recessive optic atrophy plus syndrome · Autosomal recessive optic atrophy type 3 · Costeff optic atrophy syndrome · Costeff syndrome · Infantile optic atrophy with chorea and spastic paraplegia · MGA3

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

3-methylglutaconic aciduria type III (MGA III) is an organic aciduria characterised by the association of optic atrophy and choreoathetosis with 3-methylglutaconic aciduria.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
en3-methylglutaconic aciduria type 3Autosomal recessive optic atrophy plus syndrome · Autosomal recessive optic atrophy type 3 · Costeff optic atrophy syndrome · Costeff syndrome · Infantile optic atrophy with chorea and spastic paraplegia · MGA3
frAcidurie 3-méthylglutaconique type 3AMG3 · Atrophie optique de Costeff · Atrophie optique type 3 autosomique récessive · Syndrome d'atrophie optique-plus autosomique récessif · Syndrome de Costeff
de3-Methylglutaconazidurie Typ 3Costeff-Syndrom · MGA 3 · Optikusatrophie plus-Syndrom, autosomal-rezessives · Optikusatrophie, autosomal-rezessive, Typ 3 · Optikusatrophie, infantile, mit Chorea und spastischer Paraplegie · Optikusatrophie-Syndrom Typ Costeff
esAciduria 3-metilglutacónica tipo 3Atrofia óptica autosómica recesiva tipo 3 · Atrofia óptica infantil con corea y paraplejía espástica · MGA 3 · Síndrome de Costeff · Síndrome de atrofia óptica de Costeff · Síndrome de atrofia óptica plus autosómica recesiva
itAciduria 3-metilglutaconica, tipo 3Atrofia ottica autosomica recessiva, tipo 3 · Atrofia ottica infantile con corea e paraplegia spastica · MGA 3 · MGA3 · Sindrome atrofia ottica plus, autosomica recessiva · Sindrome da atrofia ottica di Costeff · Sindrome di Costeff
nl3-methylglutaconacidurie type 3MGA3 · Opticusatrofiesyndroom van Costeff · Syndroom van Costeff · Autosomaal recessieve opticusatrofie type 3 · Autosomaal recessieve opticusatrofie-plus-syndroom · Infantiele opticusatrofie met chorea en spastische paraplegie
ptAcidúria 3-metilglutacónica tipo 3Atrofia óptica autossómica recessiva tipo 3 · Atrofia óptica infantil com coreia e paraplegia espástica · MGA3 · Síndrome Costeff · Síndrome de atrofia óptica Costeff · Síndrome de atrofia ótica plus autossómica recessiva
plKwasica 3-metyloglutakonowa typu 3Autosomal recessive optic atrophy plus syndromeAutosomalny recesywny zespół zaniku nerwu wzrokowego plus · Autosomalny recesywny zanik nerwu wzrokowego typu 3 · Dziecięcy zanik nerwu wzrokowego z pląsawicą i paraplegią spastyczną · MGA3 · Zespół Costeffa · Zespół zaniku nerwu wzrokowego Costeffa
cs3-methylglutakonová acidurie, typ 3Syndrom Costeffovy atrofie optiku · Infantilní atrofie optiku s choreou a spastickou paraplegií · MGA3 · Syndrom autozomálně recesivní atrofie optiku plus · Autozomálně recesivní atrofie optiku, typ 3 · Costeffův syndrom
uk3-метилглутаконова ацидурія, тип 3Синдром аутосомно-рецесивної атрофії зорового нерва плюс · Аутосомно-рецесивна атрофія зорового нерва, тип 3 · Синдром атрофії зорового нерва Костеффа · Синдром Костеффа · Дитяча атрофія зорового нерва з хореєю та спастичною параплегією · MGA3
zh3-甲基戊二酸尿症3型小儿视神经萎缩伴舞蹈症和痉挛性截瘫
tr3-metilglutakonik asidüri tip 3MGA3 · Costeff sendromu · Costeff optik atrofi sendromu · Otozomal Çekinik optik atrofi tip 3 · Otozomal Çekinik optik atrofi artı sendromu · Kore ve spastik paraplejili infantil optik atrofi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM258501Evalidated
ICD-10E71.1NTBTattributedvalidated
ICD-115C50.E0NTBTindexvalidated
MONDO0009787Evalidated
MeSHC535311Evalidated
UMLSC0574084Evalidated
GARD5663Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
MICOS13Disease-causing germline mutation(s) inAssessedHGNC:33702ENSG0000017491761665819p13.3mitochondrial contact site and cristae organizing system subunit 1327485409[PMID]
OPA3Disease-causing germline mutation(s) inAssessedHGNC:8142ENSG0000012574160658019q13.32outer mitochondrial membrane lipid metabolism regulator OPA320301646[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

9 annotations · validated 2016-06-01
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:00035353-Methylglutaconic aciduria
HP:0001266Choreoathetosis
HP:0000505Visual impairment
Frequent (79-30%)
HP:0001251Ataxia
HP:0001260Dysarthria
HP:0001249Intellectual disability
HP:0000639Nystagmus
HP:0002313Spastic paraparesis
Occasional (29-5%)
HP:0001288Gait disturbance

Run the differential on the 3 obligate / very frequent terms

7

Sources for this card